| RF+ (n= 162) vs RF- (n= 94) | Anti-CCP + (n= 148) vs anti-CCP- (n= 108) | Anti-MCV+ (n= 180) vs anti-MCV- (n= 74) | Anti-CII + (> 200 AU/mL; n= 8) versus anti-CII- (n= 248) |
---|---|---|---|---|
Larsen score baseline | 4.000 versus 5.000, P = NS (0.13) | 4.000 versus 5.000, P = NS (0.16) | 4.375 versus 5.000, P = NS (0.21) | 13.750 versus 4.375, P = 0.0486* |
Larsen score 1 year | 10,500 versus10.500, P = NS (0.65) | 10.500 versus 10,750, P = NS (0.66) | 11.000 versus 10.000, P = NS (0.99) | 21.500 versus 10.500, P = NS (0.0799) |
Larsen score 2 years | 14.000 versus 13.250, P = NS (0.69) | 14.000 versus 13.000, P = NS (0.57) | 14.375 versus 10,250, P = NS (0.24) | 24.000 versus 13.500, P = NS (0.19) |
ΔLarsen score 1 yr -baseline | 4.500 versus 4.250, P = NS (0.32) | 4.500 versus 4.250, P = NS (0.29) | 4.500 versus 3.750, P = NS (0.19) | 7.375 versus 4.250, P = NS (0.27) |
ΔLarsen score 2 yrs -baseline | 7.250 versus 6.250, P = 0.0354* | 7.500 versus 6.250 P = 0.0102* | 7.750 versus 5.250, P = 0.0028* | 9.250 versus 6.500, P = NS (0.50) |
ΔLarsen score 2 yrs -1 yr | 2.500 versus 1.250, P = 0.0009* | 2.750 versus 1.000, p < 0.0001* | 2.750 versus 1.000, p < 0.0001* | 3.000 versus 2,.250, P = NS (0.48) |